EGFR GENE MUTATION
Clinical trials for EGFR GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new EGFR GENE MUTATION trials appear
Sign up with your email to follow new studies for EGFR GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for lung cancer patients with brain tumors
Disease control CompletedThis study tested a new drug, AZD3759, against standard treatments for people with advanced lung cancer that has spread to the brain. The drug is designed to better reach and attack cancer cells in the brain. The trial involved 492 adults and found that AZD3759 helped keep the ca…
Matched conditions: EGFR GENE MUTATION
Phase: PHASE2, PHASE3 • Sponsor: Alpha Biopharma (Jiangsu) Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 02:19 UTC
-
Experimental combo shows promise against tough cancers
Disease control CompletedThis study tested a combination of two drugs—sEphB4-HSA and pembrolizumab—in 42 people with advanced non-small cell lung cancer or head & neck cancer that had spread or come back. The goal was to see if the combo could shrink tumors better than standard treatments. Participants h…
Matched conditions: EGFR GENE MUTATION
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
New combo offers hope for lung cancer patients resistant to targeted drugs
Disease control CompletedThis study tested a combination of chemotherapy (platinum and pemetrexed) plus an immunotherapy drug (atezolizumab), with or without another drug (bevacizumab), in 150 adults with advanced non-squamous lung cancer that has specific gene changes (EGFR, ALK, or ROS1) and has stoppe…
Matched conditions: EGFR GENE MUTATION
Phase: PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated May 15, 2026 11:52 UTC